Ostéoporose [Osteoporosis]

Details

Ressource 1Download: 56-8_42870.pdf (114.30 [Ko])
State: Public
Version: Final published version
License: Not specified
Serval ID
serval:BIB_1352CDA98BB8
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Ostéoporose [Osteoporosis]
Journal
Revue medicale suisse
Author(s)
Gonzalez Rodriguez E., Debrach-Schneider A.C., Lamy O.
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Publication state
Published
Issued date
19/01/2022
Peer-reviewed
Oui
Volume
18
Number
764-5
Pages
56-58
Language
french
Notes
Publication types: Journal Article ; Review
Publication Status: ppublish
Abstract
The year 2021 is marked by several articles aimed at better risk stratification of osteoporosis to define the groups of patients at very high risk of fractures or at imminent risk of fractures. This stratification determines who should benefit from a first line bone anabolic treatment. A review of the current state of osteoporosis was therefore essential; it shows that Switzerland is lagging. In terms of prevention of bone fragility, dairy products are probably a leading strategy, especially in the elderly. The practical management of denosumab discontinuation is finally better understood. Finally, with the arrival of a new treatment, Burosumab, we are experiencing a therapeutic revolution for rare hypophosphatemic diseases.
Keywords
Aged, Bone Density, Bone Density Conservation Agents/therapeutic use, Denosumab/therapeutic use, Humans, Osteoporosis/drug therapy, Osteoporosis/epidemiology, Osteoporosis, Postmenopausal, Osteoporotic Fractures/epidemiology, Osteoporotic Fractures/prevention & control, Switzerland
Pubmed
Create date
31/01/2022 12:56
Last modification date
05/02/2022 8:08
Usage data